I guidelines on consumption of fats and cardiovascular health;I diretriz sobre o consumo de gorduras e saúde cardiovascular

Arquivos Brasileiros de Cardiologia

Volumn 100, Issue 1 SUPPL. 3, 2013, Pages 1-40

  Santos, R D ^a   Gagliardi, A C M ^a   Xavier, H T ^a   Magnoni, C D ^a   Cassani, R ^a   Lottenberg, A M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; FAT INTAKE;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIETARY FATS; EVIDENCE-BASED MEDICINE; HUMANS; RISK FACTORS;

EID: 84876766320     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.2013S003     Document Type: Article

References (336)

1. Organização Mundial da Saúde (OMS). Cardiovacular Diseases (CVDs). Fact Sheet n° 317; 2011. [Citado em 2011 out 24].Disponrvel em: Disponível em http://www.who.int/mediacentre/factsheets/fs317/en/index.html.
2. Ministério da Saúde. DATASUS. Indicadores e dados basicos-Brasil-2009. [Citado em 2011 out 24]. Disponível em: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?idb2009/c04.def
3. Sociedade Brasileira de Cardiologia/Sociedade Brasileira de Hipertensao/Sociedade Brasileira de Nefrologia. VI Diretrizes brasileiras de hipertensao. Arq Bras Cardiol. 2010;95(1 supl.1):1-51.
4. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, Afiune Neto A, Souza AD, et al./Sociedade Brasileira de Cardiologia. IV Diretriz brasileira sobre dislipidemias e prevengao da aterosclerose. Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007;88(supl 1):2-19.
5. Chapman MJ, Ginsberg HN, Amarenco P Andreotti F, Boren J, Catapano AL, et al.; European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32(11):1345-61.
6. Coutinho JG, Gentil PC, Toral N. A desnutrigao e obesidade no Brasil: o enfrentamento com base na agenda unica da nutrigao. Cad Saúde Publica. 2008;24(supl 2):S332-40.
7. Instituto Brasileiro de Geografia e Estatí́stica (IBGE). Diretoria de Pesquisas, Coordenação de Trabalho e Rendimento. Pesquisa de Orgamentos Familiares 2008-2009. [Acesso em 2011 out 29]. Disponível em http://www:ibge.gov.br/home/xml/pof_2008_2009.shtm.
8. Ministério da Saúde. Guia alimentar para a populaçáo Brasileira. Promovendo a alimentação saudavel. 2006. [Acesso em 2011 out 29]. Disponível em http://nutricao.Saude.gov.br/guia_conheca.php.
9. de Salvo VL, Gimeno SG. Reprodutibilidade e validade do questionário de freqüĉncia de consumo de alimentos. Rev Saúde Publica. 2002;36(4):505-12.
10. Ribeiro AB, Cardoso MA. Construçáo de um questionário de freqüĉncia alimentar com subsfdio para programas de prevengao de doengas cronicas nao transmissfveis. Rev Nutr. 2002;15(2):239-45.
11. Slater B, Philippi ST, Marchioni DM, Fisberg RM. Validagao de questionários de freqüĉncia alimentar-QFA: consideragoes metodologicas. Rev Bras Epidemiol. 2003;6(3):200-8.
12. Connor SL, Gustafson JR, Artaud-Wild SM, Flavell DP Classick-Kohn CJ, Hatcher LF, et al. The cholesterol/saturated-fat index: an indication of the hypercholesterolaemic and atherogenic potential of food. Lancet. 1986;1(8492):1229-1232.
13. Keys A, Kimura N, Kusukawa A, Bonte-Stewart B, Larsen N, Keys MH. Lessons from serum cholesterol studies in Japan, Hawaii and Los Angeles. Ann Intern Med. 1958;48(1):83-94.
14. Keys A. Seven Countries: a multivariate analysis of atherosclerosis and coronary heart disease. Cambridge, MA: Harvard University Press;1980.
15. Lands B. A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res. 2008;47(2):77-106
16. Daumerie CM, Woollett LA, Dietschy JM. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools. Proc Natl Acad Sci USA. 1992;89(22):10797-801
17. Lee JY, Carr TP Dietary fatty acids regulate acyl-CoA: cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase in hamsters. J Nutr. 2004;134(12):3239-44
18. Spritz N, Mishkel MA. Effects of dietary fats on plasma lipids and lipoproteins: and hypothesis for the lipid-lowering effect of unsaturated fatty acids. J Clin Invest. 1969;48(1):78-86.
19. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965;17(5):281-295.
20. Kris-Etherton PM, Yu S. Individual fatty acid effects on plasma lipids and lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 Suppl):1628S-1644S.
21. Holman RT. How essential are fatty acids? JAMA. 1961;178:930-3.
22. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P Rudel LL, Appel LJ, et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902-7.
23. Moshfegh A, Goldman J, Cleveland L. What we eat in America: NHANES 2001-2002: Usual Nutrient Intakes from Food Compared to Dietary Reference Intakes. Beltsville, MD: US Department of Agriculture, Agricultural Research Service; 2005.
24. Sommerfeld M. Trans unsaturated fatty acids in natural products and processed foods. Prog Lipid Res. 1983;22(3):221-33.
25. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet. II. The effect of cholesterol in the diet. Metabolism. 1965;14(7):759-65.
26. Beveridge JM, Connell WF, Mayer GA, Haust HL. The response of man to dietary cholesterol. J Nutr. 1960;71:61-5.
27. Connor WE, Hodges RE, Bleiler RE. Effect of dietary cholesterol upon serum lipids in man. J Lab Clin Med. 1961;57:331-942.
28. Connor WE, Hodges RE, Bleiler RE. The serum lipids in men receiving high cholesterol and cholesterol-free diets. J Clin Invest. 1961;40:894-901.
29. Steiner A, Howard EJ, Kgun S. Importance of dietary cholesterol in man. JAMA. 1962;181:186-90.
30. Grande F, Anderson JT, Chlouverakis C. Proja M, Keys A. Effect of dietary cholesterol on man's serum lipids. J Nutr. 1965;87(1):52-62.
31. Mattson FH, Erickson BA, Kligman AM. Effect of dietary cholesterol on serum cholesterol in man. Am J Clin Nutr. 1972;25(6):589-94.
32. National Diet-Heart Study. Research Group. National Diet-Heart Study Final Report. Update. Circulation. 1968;37(Suppl 1):II1428.
33. Billett MA, Bruce JS, White DA, Bennett AJ, Salter AM. Interactive effects of dietary cholesterol and different saturated fatty acids on lipoprotein metabolism in the hamster. Br J Nutr. 2000;84(4):439-47.
34. Tso TK, Park S, Tsai YH, Williams G, Snook JT. Effect of apolipoprotein E polymorphism on serum lipoprotein response to saturated fatty acids. Lipids. 1998;33(2):139-48.
35. Sarkkinen E, Korhonen M, Erkkila A, Ebeling T, Uusitupa M. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr. 1998;68(6):1215-22.
36. Clarke R, Frost C, Collins R, Appleby P Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997;314(7074):112-117.
37. Howell WH, McNmara DJ, Tosca MA, Smith BT, Gaines JA. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr. 1997;65(6):1747-64.
38. McGill HC. The relationship of dietary cholesterol to serum cholesterol concentration and to atherosclerosis in man. Am J Clin Nutr. 1979;32(12 Suppl):2664-702.
39. Hopkins PN, Heiss G, Ellison RC, Province MA, Pankow JS, Eckfeldt JH, et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung and Blood Institute Family Heart Study. Circulation. 2003;108(5):519-23.
40. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet. 1988;2(8622):1261.
41. Campos H, D'Agostino M, Ordovas JM. Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake. Genet Epidemiol. 2001;20(1):117-128.
42. Agren JJ, Hallikainen M, Vidgren H, Miettinen TA, Gylling H. Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency. Clin Chim Acta. 2006;366(1-2):309-15.
43. Food and Nutrition Information Center. DRI. Report-Energy,Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Baltimore: National Academy of Sciences. Institute of Medicine., Food and Nutrition Board; 2005.p.107-237, 769-879.
44. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
45. American Heart Association. AHA. Diagnosis and management of the metabolic syndrome. Circulation.2005;12:2735-52.
46. McNamara DJ. The impact of egg limitations on coronary heart disease risk: do the numbers add up? J Am Coll Nutr. 2000;19(5 Suppl):540S-548S.
47. Hu FB, Stampfer MJ, Manson JE, Ascherio A, Colditz GA, Speizer FE, et al. Dietary saturated fat and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr. 1999;70:1001-8.
48. Hopkins PN. Effects of dietary cholesterol on serum cholesterol: a metaanalysis and review. Am J Clin Nutr. 1992;55(6):1060-70.
49. Djousse L, Gaziano JM. Egg consumption in relation to cardiovascular disease and mortality: the Physician's Health Study. Am J Clin Nutr. 2008;87(4):964-9.
50. Zelman K. The great fat debate: a closer look at the controversy-questioning the validity of age-old dietary guidance. J Am Diet Assoc. 2011;111(5):655-8.
51. Keys A. Effects of different dietary fats on plasma-lipid levels. Lancet. 1965;1(7380):318-9.
52. Mensink RP Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12(8):911-919.
53. Mensink RP Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146-55.
54. Van Horn L, McCoin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, et al. The evidence for dietary prevention and treatment of cardiovascular disease. J Am Diet Assoc. 2008;108(2):287-331.
55. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010:45(10):893-905.
56. Sri-Tarino PW, Sun Q, Hu FB, Krauss RM. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr. 2010;91(3):502-9.
57. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):655-66.
58. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):629-42.
59. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425-32.
60. Food and Agriculture Organization, World Health Organization. Ann Nutr Metab. 2009;91:502-9.
61. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. Plos Med. 2010;7(3):e1000252.
62. Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol. 1979;8(2):99-118.
63. Leren P The Oslo diet-heart study: eleven-year report. Circulation. 1970;42(5):935-942.
64. German JB, Gibson RA, Krauss RM, Nestel P Lamarche B, van Staveren WA, et al. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr. 2009;48(4):191-203.
65. Smit LA, Baylin A, Campos H. Conjugated linoleic acid in adipose tissue and risk of myocardial infarction. Am J ClinNutr. 2010;92(1):34-40.
66. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008; 359(3):229-41.
67. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, et al. A prospective study of nutritional factors and hypertension among US men. Circulation. 1992;86(5):1475-84.
68. Stamler J, Caggiula A, Grandits GA, Kjelsberg M, Cutler JA. Relationship to blood pressure of combinations of dietary macronutrients. Findings of the Multiple Risk Factor Intervention Trial (MRFIT). Circulation. 1996;94(10):2417-23.
69. Sudheendran S, Chang CC, Deckelbaum RJ. N-3 vs. saturated fatty acids: effects on the arterial wall. Prostaglandins Leukot Essent Fatty Acids. 2010;82(4-6):205-9.
70. Yamagishi K, Iso H, Yatsuya H, Tanabe N, Date C, Kikuchi S, et al. Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study. Am J Clin Nutr. 2010;92(4):759-65.
71. Mozaffarian D, Rimm EB, Herrington DM. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr. 2004;80(5):1175-84.
72. de Roos N, Schouten E, Katan M. Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids. J Nutr. 2001;131(2):242-5.
73. Lipoeto NI, Agus Z, Oenzil F, Wahlqvist M, Wattanapenpaiboon N. Dietary intake and the risk of coronary heart disease among the coconutconsuming Minangkabau in West Sumatra, Indonesia. Asia Pac J Clin Nutr. 2004;13(4):377-84.
74. Kumar PD. The role of coconut and coconut oil in coronary heart disease in Kerala, south India. Trop Doct. 1997;27(4):215-7.
75. Assungao ML, Ferreira HS, dos Santos AF, Cabral CR Jr, Florencio TM. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids. 2009;44(7):593-601.
76. Lecker JL, Matthan NR, Billheimer JT, Rader DJ, Lichtenstein AH. Impact of dietary fat type within the context of altered cholesterol homeostasis on cholesterol and lipoprotein metabolism in the F1 B hamster. Metabolism. 2010;59(10):1491-501.
77. Edem DO. Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review. Plant Foods Hum Nutr. 2002;57(3-4):319-41.
78. Vega-Lopez S, Ausman LM, Jalbert SM, Erkkila AT, Lichtenstein AH. Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr. 2006;84(1):54-62.
79. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985;26(2):194-202.
80. Rudel LL, Haines JL, Sawyer JK. Effects on plasma lipoproteins of monounsaturated, saturated, and polyunsaturated fatty acids in the diet of African green monkeys. J Lipid Res. 1990;31(10):1873-82.
81. Denke MA, Grundy SM. Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr. 1992;56(5):895-8.
82. Zock PL, de Vries JH, Katan MB. Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Arterioscler Thromb. 1994;14(4):567-75.
83. Cuesta C, Rodenas S, Merinero MC, Rodriguez-Gil S, Sanchez-Muniz FJ. Lipoprotein profiles and serum peroxide levels of aged women consuming palmolein or oleic acid-rich sunflower oil diets. Eur J Clin Nutr. 1998;52(9):675-83.
84. Rudel LL, Parks JS, Sawyer JK. Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15(12):2101-10.
85. Ministério da Saúde. Agencia Nacional de Vigilancia Sanitaria.(ANVISA). Legislagao. VisaLegis. Resolugao RDC n.264, de 22 de setembro de 2005: aprova regulamento tecnico para fixagao de identidade e qualidade de chocolate e chocolate branco.[Citado em 2010 nov 10]. Disponfvel em: http://e-legis.anvisa.gov.br/leisref/public/showAct.ph?id=18823&word=chocolate
86. Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CC, Schmitz HH, et al. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr. 2000;130(8S Suppl):2115S-9S.
87. Ministério da Agricultura, do Abastecimento e da Reforma Agrária. Gabinete do Ministro. Regulamento tecnico de identidade e qualidade de manteiga. Portaria n.146 de 07 de margo de 1996. [Citado em 2010 jan 08].Dispomvel em: http://www.agais.com/normas/leite/manteiga.htm
88. Richards NSPS. Desenvolvimento e caracterizagao de manteigas aromatizadas [Tese]. Sao Paulo; Faculdade de Ciencias Farmaceuticas. Universidade de Sao Paulo;2001.
89. Judd JT, Baer DJ, Clevidence BA, Muesing RA, Chen SC, Westrate JA, et al. Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets. Am J Clin Nutr. 1998;68(4):768-77.
90. Han SN, Leka LS, Lichtenstein AH, Ausman LM, Schaefer EJ, Meydani SN. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res. 2002;43(3):445-52.
91. Gagliardi AC; Maranhao RC, de Souza HP Schaefer EJ, Santos RD. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome. Eur J Clin Nutr. 2010;64(10):1141-9.
92. Salles-Filho S, Zackiewics M. Prioridade de pesquisa para sumos e aves. Revista TeC Carnes. 2001;3(1):1-6.
93. Rocha YR, Aguiar JPL, Marinho HA, Shrimpton R. Aspectos nutritivos de alguns peixes da Amazônia. Acta Amazonica. 1982;12(4):787-94.
94. Ministério do Desenvolvimento, Indústria e Comércio Exterior. Instituto Nacional de Metrologia, Qualidade e Tecnologia.(INMETRO).Aves-Teor de gordura e colesterol em alimentos-3° Parte. Informagoes ao consumidor. Carnes bovina e suma-Teor de gordura e colesterol em alimentos. Brasilia;2001.
95. Ministério do Desenvolvimento, Indústria e Comércio Exterior. Instituto Nacional de Metrologia, Qualidade e Tecnologia.(INMETRO).Miudos, vfsceras e peixes-Teor de gordura e colesterol em alimentos-2° Parte. Brasilia;2001.
96. de Lorgeril M, Salen P Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-85.
97. De Biase SG, Fernandes SF, Gianini RJ, Duarte JL. Vegetarian diet and cholesterol and triglycerides levels. Arq Bras Cardiol. 2007;88(1):35-9.
98. Ministério do Desenvolvimento, Indústria e Comércio Exterior. Instituto Nacional de Metrologia, Qualidade e Tecnologia.(INMETRO). Programa de análise de produtos-analisa teor de gordura e de colesterol de queijos. [Citado em 2011 nov 10]. Disponível em: http://www.brasil.gov.br/noticias/arquivos/2011/08/01/inmetro-analisa-teor-de-gordura-e-de-colesterol
99. Universidade Estadual de Campinas.(UNICAMP). Núcleo de estudos e pesquisas em alimentação.NEPA. Tabela brasileira de composigao de alimentos-TACO-Versao 2.Campinas;2006.
100. Kris-Etherton PM, Pearson TA, Wan Y, Hargrove RL, Moriarty K, Fishell V, et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr. 1999;70(6):1009-15.
101. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med. 1986;314(12):745-8.
102. Mensink RP Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet. 1987;1(8525):122-5.
103. Kastorine CM, Milionis HJ, Esposito K, Giuliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol. 2011;57(11):1299-1313.
104. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb. 1994;14(4):557-66.
105. Reaven P Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, et al. Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans. Am J Clin Nutr. 1991;54(4):701-6.
106. Astrup A. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359(20):2169-70.
107. Lopez S, Bermudez B, Ortega A, Varela LM, Pacheco YM, Villar J, et al. Effects of meals rich in either monounsaturated or saturated fat on lipid concentrations and on insulin secretion and action in subjects with high fasting triglyceride concentrations. Am J Clin Nutr. 2011;93(3):494-9.
108. Paniagua JA, de La Sacristana AG, Sanchez E, Romero I, Vidal-Puig A, Berral FJ, et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007;26(5):434-44.
109. Xiao C, Giacca A, Carpentier A, Lewis GF. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia. 2006;49(6):1371-9.
110. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288(20):2554-60.
111. Risérus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res. 2009;48(1):44-51.
112. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, et al.; KANWU Study. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001;44(3):312-9.
113. Perez-Jimenez F, López-Miranda J, Pinillos MD, Gomez P, Paz-Rojas E, Montilla P et al. A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons. Diabetologia. 2001;44(11):2038-43.
114. Paniagua JA, Gallego de la Sacristana A, Romero I, Vidal-Puig A, Latre JM, Sanchez E, et al. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care. 2007;30(7):1717-23.
115. Louheranta AM, Sarkkinen ES, Vidgren HM, Schwab US, Uusitupa MI. Association of the fatty acid profile of serum lipids with glucose and insulin metabolism during 2 fat-modified diets in subjects with impaired glucose tolerance. Am J Clin Nutr. 2002;76(2):331-7.
116. Brynes AE, Edwards CM, Jadhav A, Ghatei MA, Bloom SR, Frost GS. Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am J Clin Nutr. 2000;72(5):1111-8.
117. Alonso A, Ruiz-Gutierrez V Martinez-Gonzalez MA. Monounsaturated fatty acids, olive oil and blood pressure: epidemiological, clinical and experimental evidence. Public Health Nutr. 2006;9(2):251-7.
118. Rasmussen BM, Vessby B, Uusitupa M, Berglund L, Pedersen E, Riccardi G, et al.; KANWU Study Group. Effects of dietary saturated, monounsaturated, and n-3 fatty acids on blood pressure in healthy subjects. Am J Clin Nutr. 2006;83(2):221-6.
119. WittemanJC, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, et al. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989;80(5):1320-7.
120. AscherioA, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, et al. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension. 1996;27(5):1065-72.
121. Stamler J, Liu K, Ruth KJ, Pryer J, Greenland P Eight-year blood pressure change in middle-aged men: relationship to multiple nutrients. Hypertension. 2002;39(5):1000-6.
122. WilliamsPT, Fortmann SP Terry RB, Garay SC, Vranizan KM, Ellsworth N, et al. Associations of dietary fat, regional adiposity, and blood pressure in men. JAMA. 1987;257(23):3251-6.
123. TrevisanM, Krogh V, Freudenheim J, Blake A, Muti P Panico S, et al. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. The Research Group ATS-RF2 of the Italian National Research Council. JAMA. 1990;263(5):688-92.
124. Psaltopoulou T, Naska A, Orfanos P Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2004;80(4):1012-8.
125. AlonsoA, Martinez-Gonzalez MA. Olive oil consumption and reduced incidence of hypertension: the SUN study. Lipids. 2004;39(12):1233-8.
126. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER 3rd, et al.; OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA. 2005;294(19):2455-64.
127. López-Miranda J, Badimon L, Bonanome A, Lairon D, Kris-Etherton PM, Mata P et al. Monounsaturated fat and cardiovascular risk. Nutr Rev. 2006;10(Suppl 4):S2-12.
128. Perez-JimenezF, Alvarez de Cienfuegos G, Badimon L, Barja G, Battino M, Blanco A, et al. International conference on the healthy effect of virgin olive oil.Eur J Clin Invest. 2005;35(7):421-4.
129. Delgado-ListaJ, Garcia-Rios A, Perez-Martinez P, López-Miranda J, Perez-Jimenez F. Olive oil and haemostasis: platelet function, thrombogenesis and fibrinolysis. Curr Pharm Des. 2011;17(8):778-85.
130. KeysA. Coronary heart disease in seven countries. Circulation. 1970;41(4 suppl):1-198.
131. Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: a paradox. Circulation. 1993;88(6):2771-9.
132. Pietinen P Ascherio A, Korhonen P Hartman AM, Willett WC, Al Banes D, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145(10):876-87.
133. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169(7):659-69.
134. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189(1):19-30.
135. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 Suppl):1645S-1654S.
136. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008;(1):CD003205.
137. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al.; American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular N. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-333.
138. Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr. 2008;87(6):1981S-90S.
139. Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care. 2001;24(9):1528-35.
140. Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, Hu FB. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr. 2009;90(3):613-20.
141. Brostow DP Odegaard AO, Koh WP Duval S, Gross MD, Yuan JM, et al. Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2011;94(2):520-6.
142. Djousse L, Biggs ML, Lemaitre RN, King IB, Song X, Ix JH, et al. Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr. 2011;94(2):527-33.
143. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes: a meta-analysis. Diabetes Care. 1998;21(4):494-500.
144. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20(8):1493-9.
145. Grynberg A. Hypertension prevention: from nutrients to (fortified) foods to dietary patterns: focus on fatty acids. J Hum Hypertens. 2005;19(Suppl 3):S25-33.
146. de Roos B, Mavrommatis Y Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol. 2009;158(2):413-28.
147. Saravanan P Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376(9740):540-50.
148. Lopez-Garcia E, Schulze MB, Manson JE, Meigs JB, Albert CM, Rifai N, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr. 2004;134(7):1806-11.
149. Niu K, Hozawa A, Kuriyama S, Ohmori-Matsuda K, Shimazu T, Nakaya N, et al. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr. 2006;84(1):223-9.
150. Micallef MA, Munro IA, Garg ML. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr. 2009;63(9):1154-6.
151. Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul Study Atherosclerosis. 2009;205(2):538-43.
152. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol. 2001;88(10):1139-42.
153. Rizza S, Tesauro M, Cardillo C, Galli A, Iantorno M, Gigli F, et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis. 2009;206(2):569-74.
154. Kelley DS, Siegel D, Fedor DM, Adkins Y Mackey BE. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr. 2009;139(3):495-501.
155. Murphy KJ, Meyer BJ, Mori TA, Burke V, Mansour J, Patch CS, et al. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr. 2007;97(4):749-57.
156. Petersson H, Risérus U, McMonagle J, Gulseth HL, Tierney AC, Morange S, et al. Effects of dietary fat modification on oxidative stress and inflammatory markers in the LIPGENE study. Br J Nutr. 2010;104(9):1357-62.
157. Madsen T, Christensen JH, Schmidt EB. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study. Eur J Nutr. 2007;46(7):428-30.
158. Madsen T, Christensen JH, Blom M, Schmidt EB. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr. 2003;89(4):517-22.
159. Egert S, Stehle P Impact of n-3 fatty acids on endothelial function: results from human interventions studies. Curr Opin Clin Nutr Metab Care. 2011;14(2):121-31.
160. Wang HH, Hung TM, Wei J, Chiang AN. Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res. 2004;61(1):169-76.
161. Zampolli A, Bysted A, Leth T, Mortensen A, De Caterina R, Falk E. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis. 2006;184(1):78-85.
162. Saraswathi V, Gao L, Morrow JD, Chait A, Niswender KD, Hasty AH. Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr. 2007;137(7):1776-82.
163. Casós K, Sáiz MP Ruiz-Sanz JI, Mitjavila MT. Atherosclerosis prevention by a fish oil-rich diet in apoE(-/-) mice is associated with a reduction of endothelial adhesion molecules. Atherosclerosis. 2008;201(2):306-17.
164. Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y et al. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. Atherosclerosis. 2008;197(2):524-33.
165. Xu Z, Riediger N, Innis S, Moghadasian MH. Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice. Eur J Nutr. 2007;46(2):103-10.
166. Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, Abbott RD, et al.; ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol. 2008;52(6):417-24.
167. Heine-Broring RC, Brouwer IA, Proenga RV van Rooij FJ, Hofman A, Oudkerk M, et al. Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am J Clin Nutr. 2010;91(5):1317-23.
168. He K, Liu K, Daviglus ML, Mayer-Davis E, Jenny NS, Jiang R, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr. 2008;88(4):1111-8.
169. von Schacky C, Angerer P Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130(7):554-62.
170. Angerer P, Kothny W, Stork S, von Schacky C. Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res. 2002;54(1):183-90.
171. Mita T, Watada H, Ogihara T, Nomiyama T, Ogawa O, Kinoshita J, et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis. 2007;191(1):162-7.
172. Thies F, Garry JM, Yaqoob P Rerkasem K, Williams J, Shearman CP et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361(9356):477-85.
173. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757-61.
174. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354(9177):447-55.
175. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P Ashton T, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57(2):193-200.
176. Svensson M, Schmidt EB, Jorgensen KA, Christensen JH; OPACH Study Group. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol. 2006;1(4):780-6.
177. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y et al.; Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369(9567):1090-8.
178. Gissi-HF Investigators, Tavazzi L, Maggioni AP Marchioli R, Barlera S, Franzosi MG, Latini R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223-30.
179. Kromhout D, Giltay EJ, Geleijnse JM; Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363(21):2015-26.
180. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, et al.; OMEGA Study Group. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122(21):2152-9.
181. Galan P Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S; SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ. 2010;341:c6273.
182. Bucher HC, Hengstler P Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112(4):298-304.
183. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev. 2004;(4):CD003177.
184. He K, Song Y Daviglus ML, Liu K, Van Horn L, Dyer AR, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a metaanalysis of cohort studies. Circulation. 2004;109(22):2705-11.
185. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84(1):5-17.
186. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885-99.
187. Leon H, Shibata MC, Sivakumaran S, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008;337:a2931.
188. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32(7):365-72.
189. Marchioli R, Barzi F Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al.; GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105(16):1897-903.
190. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, et al.; Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112(18):2762-8.
191. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293(23):2884-91.
192. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45(12):2015-21.
193. YamagishiK, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, et al.; Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol. 2008;52(12):988-96.
194. WatsonPD, Joy PS, Nkonde C, Hessen SE, Karalis DG. Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel--versus--aspirin + clopidogrel in patients with cardiovascular disease. Am J Cardiol. 2009;104(8):1052-4.
195. EritslandJ, Arnesen H, Seljeflot I, Kierulf P Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis. 1995;6(1):17-22.
196. WendlandE, Farmer A, Glasziou P, Neil A. Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart. 2006;92(2):166-169.
197. Prasad K. Flaxseed and cardiovascular health. J Cardiovasc Pharmacol. 2009;54(5):369-77.
198. Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, et al. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr. 2008;27(1):65-74.
199. YoneyamaS, Miura K, Sasaki S, Yoshita K, Morikawa Y, Ishizaki M, et al. Dietary intake of fatty acids and serum C-reactive protein in Japanese. J Epidemiol. 2007;17(3):86-92.
200. Poudel-TandukarK, Nanri A, Matsushita Y Sasaki S, Ohta M, Sato M, et al. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men. Nutr Res. 2009;29(6):363-70.
201. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167(2):237-42.
202. PaschosGK, Rallidis LS, Liakos GK, Panagiotakos D, Anastasiadis G, Votteas V, et al. Background diet influences the anti-inflammatory effect of alpha-linolenic acid in dyslipidaemic subjects. Br J Nutr. 2004;92(4):649-55.
203. Mozaffarian D. Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence. Altern Ther Health Med. 2005;11(3):24-30.
204. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation. 2005;111(2):157-64.
205. AlbertCM, Oh K, Whang W Manson JE, Chae CU, Stampfer MJ, et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112(21):3232-8.
206. BrouwerIA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr. 2004; 134(4):919-22.
207. Lichtenstein AH, Schwab US. Relationship of dietary fat to glucose metabolism. Atherosclerosis. 2000;150(2):227-43.
208. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001;73(6):1019-26.
209. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care. 2002;25(3):417-24.
210. Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van der Veen EA. Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic patients. Am J Clin Nutr. 1989;49(3):448-56.
211. Summers LK, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45(3):369-77.
212. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids. 2005;73(3-4):141-62.
213. Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285(5431):1276-9.
214. Petersson H, Basu S, Cederholm T, Risérus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men. Br J Nutr. 2008;99(6):1186-9.
215. Petersson H, Lind L, Hulthe J, Elmgren A, Cederholm T, Risérus U. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis. 2009;203(1):298-303.
216. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007;193(1):1-10.
217. Miettinen M, Turpeinen O, Karvonen MJ, Pekkarinen M, Paavilainen E, Elosuo R. Dietary prevention of coronary heart disease in women: the Finnish mental hospital study. Int J Epidemiol. 1983;12(1):17-25.
218. Frantz ID Jr, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, et al. Test of effect of lipid lowering by diet on cardiovascular risk: the Minnesota Coronary Survey. Arteriosclerosis. 1989;9(1):129-35.
219. Kris-Etherton P Fleming J, Harris WS. The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. J Am Diet Assoc. 2010;110(2):201-4.
220. Lloyd-Williams F, O'Flaherty M, Mwatsama M, Birt C, Ireland R, Capewell S. Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. Bull World Health Organ. 2008;86(7):535-41A.
221. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010;104(11):1586-600.
222. Simopoulos AP The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56(8):365-79.
223. Simopoulos AP Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006;60(9):502-7.
224. Gomez Candela C, Bermejo Lopez LM, Loria Kohen V. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp. 2011;26(2):323-9.
225. de Lorgeril M, Renaud S, Mamelle N, Salen P Martin JL, Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343(8911):1454-9.
226. Harris WS. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep. 2006;8(6):453-9.
227. Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol. 2008;19(1):57-62.
228. Liou YA, King DJ, Zibrik D, Innis SM. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr. 2007;137(4):945-52.
229. Brouwer IA, Wanders AJ, Katan MB. Effect of animal and Indústrial trans fatty acids on HDL and LDL cholesterol levels in humans--a quantitative review. PLoS One. 2010;5(3):e9434.
230. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. Trans fatty acids and coronary heart disease. N Engl J Med. 1999;340(25):1994-8.
231. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354(15):1601-13.
232. Mensink RP Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med. 1990;323(7):439-45.
233. Mozaffarian D, Aro A, Willett WC. Health effects trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr. 2009;63(Suppl 2):S5-21.
234. Niu SL, Mitchell DC, Litman BJ. Trans fatty acid derived phospholipids show increased membrane cholesterol and reduced receptor activation as compared to their cis analogs. Biochemistry. 2005;44(11):4458-65.
235. Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, et al. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004;24(6):1092-7.
236. Willett WC. The scientific basis for TFA regulations-is it sufficient? Comments from the USA. Atheroscler Suppl. 2006;7(2):69-71.
237. Matthan NR, Ausman LM, Lichtenstein AH, Jones PJ. Hydrogenated fat consumption affects cholesterol synthesis in moderately hypercholesterolemic women. J Lipid Res. 2000;41(5):834-9.
238. Machado RM, Stefano JT, Oliveira CP Mello ES, Ferreira FD, Nunes VS, et al. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tis-sue fat content. J Nutr. 2010;140(6):1127-32.
239. Verges B. Lipid modification in type 2 diabetes: the role of LDL and HDL. Fundam Clin Pharmacol. 2009;23(6):681-5.
240. Buonacorso V, Nakandakare ER, Nunes VS, Passarelli M, Quintao EC, Lottenberg AM. Macrophage cholesterol efflux elicited by human total plasma and by HDL subfractions is not affec-ted by different types of dietary fatty acids. Am J Clin Nutr. 2007;86(5):1270-7.
241. Cassagno N, Palos-Pinto A, Costet P Breilh D, Darmon M, Berard AM. Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defense to oxidative stress in mice. Br J Nutr. 2005;94(3):346-52.
242. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C, et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr. 2003;78(3):370-5.
243. Ibrahim A, Natrajan S, Ghafoorunissa R. Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism. 2005;54(2):240-6.
244. Bendsen NT, Haugaard SB, Larsen TM, Chabanova E, Stender S, Astrup A. Effect of trans fatty acid intake on insulin sensitivity and intramuscular lipids--a randomized trial in overweight postmenopausal women. Metabolism. 2011;60(7):906-13.
245. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA. Severe NAFLD with hepatic necro inflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol. 2008;295(5):G987-95.
246. Teegala SM, Willett WC, Mozaffarian D. Consumption and health effects of trans fatty acids: a review. J AOAC Int. 2009;92(5):1250-7.
247. Baer DJ, Judd JT, Clevidence BA, Tracy RP Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 2004;79(6):969-73.
248. Lichtenstein AH, Erkkila AT, Lamarche B, Schwab US, Jalbert SM, Ausman LM. Influence of hydrogenated fat and butter on CVD risk factors: remnantlike particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis. 2003;171(1):97-107.
249. Smit LA, Katan MB, Wanders AJ, Basu S, Brouwer IA. A high intake of transfatty acids has little effect on markers of inflammation and oxidative stress in humans. J Nutr. 2011;141(9):1673-8.
250. Bassett CM, McCullough RS, Edel AL, Maddaford TG, Dibrov E, Blackwood DP et al. Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism. 2009;58(12):1802-8.
251. Zapolska-Downar D, Kosmider A, Naruszewicz M. Trans fatty acids induce apoptosis in human endothelial cells. J Physiol Pharmacol. 2005;56(4):611-25.
252. McKeigueP Trans fatty acids and coronary heart disease: weighing the evidence against hardened fat. Lancet. 1995;345(8945):269-270.
253. Sun Q, Ma J, Campos H, Hu FB. Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am J Clin Nutr. 2007;86(4):929-37.
254. de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler Thromb Vasc Biol. 2001;21(7):1233-7.
255. Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ. 1996;313(7049):84-90.
256. Aro A, Kardinaal AFM, Salminen I, Kark JD, Riemersma RA, Delgado-Rodriguez M, et al. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet. 1995;345(8945):273-8.
257. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337(21):1491-9.
258. Mozzaffarian D, Willett WC. Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep. 2007;9(6):486-93.
259. Ministério da Saúde. Agencia Nacional de Vigilan cia Sanitaria (ANVISA). Resolugao-RDC (N.360, de 23 de dezembro de 2003. Diario Oficial da Uniao(DOU);2003;Brasflia, 26 dezembro, 2003.[Citado em 2010 mar 23]. Disponível em: http://e-legis.anvisa.gov.br/leisref/public/showAct.php?id=9059.
260. Eckel RH, Borra S, Lichtenstein AH, Yin-Piazza SY; Trans Fat Conference Planning Group. Understanding the complexity of trans fatty acid reduction in the American Diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation. 2007;115(16):2231-46.
261. Ohara N, Naito Y, Kasama K, Shindo T, Yoshida H, Nagata T, Okuyama H. Similar changes in clinical and pathological parameters in Wistar Kyoto rats after a 13-week dietary intake of canola oil or a fatty acid composition-based interesterified canola oil mimic. Food ChemToxicol. 2009;47(1):157-62.
262. Reena MB, Lokesh BR. Hypolipidemic effect of oils with balanced amounts of fatty acids obtained by blending and interesterification of coconut oil with rice bran oil or sesame oil. J Agric Food Chem. 2007;55(25):10461-9.
263. Reena MB, Gowda LR, Lokesh BR. Enhanced hypocholesterolemic effects of interesterified oils are mediated by upregulating LDL receptor andcholesterol 7-alpha-hydroxylase gene expression in rats. J Nutr. 2011;141(1):24-30.
264. Sundram K, Karupaiah T, Hayes KC. Stearic acid-rich interesterified fat and trans-rich fat raise the LDL/HDL ratio and plasma glucose relative to palm olein in humans. Nutr Metab (Lond). 2007;4:3.
265. Nestel PJ, Noakes M, Belling GB, McArthur R, Clifton PM. Effect on plasma lipids of interesterifying a mix edible oils. Am J Clin Nutr. 1995;62(5):950-5.
266. WangCH, Kuksis A, Manganaro F. Studies of the substrate specificity of purified human milk lipoprotein lipase. Lipids. 1982;17(4):278-84.
267. Hayes KC. Synthetic and modified glycerides: effects on plasma lipids. Curr Opin Lipidol. 2001;12(1):55-60.
268. Yli-JokipiiK, Kallio H, Schwab U, Mykkanen H, Kurvinen JP Savolainen MJ, et al. Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response. J Lipid Res. 2001;42(10):1618-25.
269. Robinson DM, Martin NC, Robinson LE, Ahmadi L, Marangoni AG, Wright AJ. Influence of interesterification of a stearic acid-rich spreadable fat on acute metabolic risk factos. Lipids. 2009;44(1):17-26.
270. Meijer GW, Westrate JA. Interesterification of fats in margarine: effect on blood lipids, blood enzymes, and hemostasis parameters. Eur J Clin Nutr. 1997;51(8):527-34.
271. Vos E, Cunnane SC, Lanzmann-Petithory D. n-3 fatty acids and cardiovascular events. N Engl J Med. 2011;364(9):880-881.
272. deKoning L, Chiuve SE, Fung TT, Willett WC, Rimm EB, Hu FB. Diet-quality scores and the risk of type 2 diabetes in men. Diabetes Care. 2011;34(5):1150-6.
273. JakobsenMU, Overvad K. Macronutrient advice for ischemic heart disease prevention. Curr Opin Lipidol. 2011;22(1):33-6.
274. WangS, Hwang H, Yoon S, Choe E. Temperature dependence of autoxidation of perilla oil and tocopherol degradation. J Food Sci. 2010;75(6):C498-505.
275. ChoeE, Min DB. Chemistry of deep-fat frying oils. J Food Sci. 2007;72(5):R77-86.
276. Spiteller G. The relation of lipid peroxidation processes with atherogenesis: a new theory on atherogenesis. Mol Nutr Food Res. 2005; 49(11):999-1013.
277. ValenzuelaA, Morgado N. Trans fatty acid isomers in human health and in the food industry. Biol Res. 1999; 32(4):273-87.
278. MisraA, Sharma R, Gulati S, Joshi SR, Sharma V Ghafoorunissa, et al.; For The National Dietary Guidelines Consensus Group. Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians. Diabetes Technol Ther. 2011;13(6):683-94.
279. Mozaffarian D, Jacobson MF, Greenstein JS. Food reformulations to reduce trans fatty acids. N Engl J Med. 2010;362(21):2037-9.
280. ThompsonAK, Minihane AM, Williams CM. Trans fatty acids, insulin resistance and diabetes. Eur J Clin Nutr. 2011; 65(5):553-64.
281. Thompson AK, Minihane AM, Williams CM. Trans fatty acids and weight gain. Int J Obes (Lond). 2011; 35(3):315-24.
282. Kendall CW Josse AR, Esfahani A, Jenkins DJ. Nuts, metabolic syndrome and diabetes. Br J Nutr. 2010;104(4):465-73.
283. Ortega RM. Importance of functional foods in the Mediterranean diet. Public Health Nutr. 2006;9(8A):1136-40.
284. Basu S. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress. Prostaglandins Leukot Essent Fatty Acids. 2010;82(4-6):219-25.
285. Silva FAM, Borges MFM, Ferreira MA. Metodos para avaliagao do grau de oxidagao lipfdica e da capacidade antioxidante. Qufmica Nova. 1999;22(1):94-103.
286. Kalua CM, Bedgood DR Jr, Bishop AG, Prenzler PD. Discrimination of storage conditions and freshness in virgin olive oil. J Agric Food Chem. 2006;54(19):7144-51.
287. Riediger ND, Othman R, Fitz E, Pierce GN, Suh M, Moghadasian MH. Low n-6:n-3 fatty acid ratio, with fish-or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice. Eur J Nutr. 2008;47(3):153-60.
288. Cintra DE, Costa AV Peluzio MC, Matta SL, Silva MT, Costa NM. Lipid profile of rats fed high-fat diets based on flaxseed, peanut, trout, or chicken skin. Nutrition. 2006;22(2):197-205.
289. Sugamura K, Keaney JF Jr. Reactive oxygen species in cardiovascular disease. Free Radic Biol Med. 2011;51(5):978-92.
290. Yamashita K, Ikeda S, Obayashi M. Comparative effects of flaxseed and sesame seed on vitamin E and cholesterol levels in rats. Lipids. 2003;38(12):1249-55.
291. Lopez-Uriarte P Bullo M, Casas-Agustench P Babio N, Salas-Salvado J. Nuts and oxidation: a systematic review. Nutr Rev. 2009;67(9):497-508.
292. Liu WH, Lu YF, Inbaraj BS, Chen BH. Formation of trans fatty acids in chicken legs during frying. Int J Food Sci Nutr. 2008;59(5):368-82.
293. Tarmizi AH, Lin SW. Quality assessment of palm products upon prolonged heat treatment. J Oleo Sci. 2008;57(12):639-48.
294. Attya M, Benabdelkamel H, Perri E, Russo A, Sindona G. Effects of conventional heating on the stability of major olive oil phenolic compounds by tandem mass spectrometry and isotope dilution assay. Molecules. 2010;15(12):8734-46.
295. Casal S, Malheiro R, Sendas A, Oliveira BP Pereira JA. Olive oil stability under deep-frying conditions. Food Chem Toxicol. 2010;48(10):2972-9.
296. Osorio VM, de Lourdes Cardeal Z. Determination of acrolein in french fries by solid-phase microextraction gas chromatography and mass spectrometry J Chromatogr A. 2011;1218(21):3332-6.
297. Ministério do Desenvolvimento, Indústria e Comércio Exterior. Instituto Nacional de Metrologia, Normalizagao e Qualidade Indústrial (INMETRO). Programa de Análise de Produtos: Relatorio sobre Análise de Gordura e Colesterol em Azeite de Oliva e de Dende. 2010, 1-19.
298. Le HD, Meisel JA, de Meijer VE, Gura KM, Puder M. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids. 2009;81(2-3):165-70.
299. Ueda Y, Kawakami Y Kunii D, Okada H, Azuma M, Le DS, et al. Elevated concentrations of linoleic acid in erythrocyte membrane phospholipids in patients with inflammatory bowel disease. Nutr Res. 2008;28(4):239-44.
300. Weaver KL, Ivester P Seeds M, Case LD, Arm JP Chilton FH. Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem. 2009;284(23):15400-7.
301. Margioris AN. Fatty acids and postprandial inflammation. Curr Opin Clin Nutr Metab Care. 2009;12(2):129-37.
302. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111-7.
303. Fresno M, Alvarez R, Cuesta N. Toll-like receptors, inflammation, metabolism and obesity. Arch Physiol Biochem. 2011;117(3):151-64.
304. Powell K. Obesity: the two faces of fat. Nature. 2007;447(7144):525-7.
305. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-7.
306. Simopoulos AP The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674-88.
307. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454(7203):470-7.
308. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875-80.
309. Libby P Inflammation in atherosclerosis. Nature. 2002;420(6917):868-74.
310. Gopinath B, Buyken AE, Flood VM, Empson M, Rochtchina E, Mitchell P Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality. Am J Clin Nutr. 2011;93(5):1073-9.
311. Ros E, Mataix J. Fatty acid composition of nuts-implications for cardiovascular health. Br J Nutr. 2006;96(Suppl 2):S29-35.
312. Williams CM, Burdge G. Long-chain n-3 PUFA: plant vs. marine sources. Proc Nutr Soc. 2006;65(1):42-50.
313. Morise A, Combe N, Boue C, Legrand P Catheline D, Delplanque B, et al. Dose effect of alpha-linolenic acid on PUFA conversion, bioavailability, and storage in the hamster. Lipids. 2004;39(4):325-34.
314. Caballeroa MJ, Obachb A, Rosenlundb G, Monteroa D, Gisvoldb M, Izquierdoa MS. Impact of different dietary lipid sources on growth, lipid digestibility, tissue fatty acid composition and histology of rainbow trout (Oncorhynchus mykiss). Aquaculture. 2002;214(1-4):253-71.
315. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet. 1979;2(8140):433-5.
316. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312(19):1205-9.
317. Fish consumption and mortality from coronary heart disease. N Engl J Med. 1985;313(13):820-4.
318. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332(15):977-82.
319. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336(15):1046-53.
320. Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R. Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila). 2011;4(11):1903-11.
321. Universidade de Sao Paulo. Faculdade de Ciencias Farmaceuticas. Departamento de Alimentos e Nutrigao Experimental/BRASILFOODS (1998). Tabela Brasileira de Composigao de Alimentos-USP Versao 5.0.[Citado em 2011 out 20] Disponfvel em: http://www.fcf.usp.br/tabela.
322. Megdal PA, Craft NA, Handelman GJ. A simplified method to distinguish farmed (Salmo salar) from wild salmon: fatty acid ratios versus astaxanthin chiral isomers. Lipids. 2009;44(6):569-76.
323. Li G, Sinclair AJ, Li D. Comparison of lipid content and Fatty Acid composition in the edible meat of wild and cultured freshwater and marine fish and shrimps from china. J Agric Food Chem. 2011;59(5):1871-1881.
324. Huynh MD, Kitts DD, Hu C, Trites AW. Comparison of fatty acid profiles of spawning and non-spawning Pacific herring, Clupea harengus pallasi. Comp Biochem Physiol B Biochem Mol Biol. 2007;146(4):504-11.
325. Bell JG, McEvoy J, Tocher DR, McGhee F, Campbell PJ, Sargent JR. Replacement of fish oil with rapeseed oil in diets of Atlantic salmon (Salmo salar) affects tissue lipid compositions and hepatocyte fatty acid metabolism. J Nutr. 2001;131(5):1535-43.
326. Somero GN, DeVries AL. Temperature tolerance of some Antarctic fishes. Science. 1967;156(3772):257-8.
327. Satue MT, Lopez MC. Sex-linked differences in fatty acid composition of rainbow trout (Oncorynchus mykiss) liver oil. Food Chem. 1996;57(3):359-63.
328. Morais S, Pratoomyot J, Taggart JB, Bron JE, Guy DR, Bell JG, et al. Genotype-specific responses in Atlantic salmon (Salmo salar) subject to dietary fish oil replacement by vegetable oil: a liver transcriptomic analysis. BMC Genomics. 2011;12:255.
329. Bell MV, Dick JR, Porter AE. Biosynthesis and tissue deposition of docosahexaenoic acid (22:6n-3) in rainbow trout (Oncorhynchus mykiss). Lipids. 2001;36(10):1153-1159.
330. Ribeiro CS, Gomes AD, Vieira VARO, Tabata YA, Takahashi NS, Moreira RG. The effect of ploidy on the fatty acid profile during the reproductive cycle of female rainbow trout (Oncorhynchus mykiss). Aquaculture Int.2011;Aug 13:1-21.[Citado em 2011 out 24].Dispomvel em:http://www.springerlink.com/content/488573k62475112x/fulltext.pdf
331. Visentainer JV, Carvalho PO, Ikegaki M, Park YK. Concentragao de acido eicosapentaenoico (EPA) e acido docosahexaenoico (DHA) em peixes marinhos da costa brasileira. Cienc Tecnol Aliment. 2000;20(1):90-3.
332. Leaver MJ, Taggart JB, Villeneuve L, Bron JE, Guy DR, Bishop SC, et al. Heritability and mechanisms of n-3 long chain polyunsaturated fatty acid deposition in the flesh of Atlantic salmon. Comp Biochem Physiol Part D Genomics Proteomics. 2011;6(1):62-9.
333. Kennedy SR, Campbell PJ, Porter A, Tocher DR. Influence of dietary conjugated linoleic acid (CLA) on lipid and fatty acid composition in liver and flesh of Atlantic salmon (Salmo salar). Comp Biochem Physiol B Biochol Biol. 2005;141(2):168-78.
334. Trattner S, Kamal-Eldin A, Brannas E, Moazzami A, Zlabek V, Larsson P et al. Sesamin supplementation increases white muscle docosahexaenoic acid (DHA) levels in rainbow trout (Oncorhynchus mykiss) fed high alpha-linolenic acid (ALA) containing vegetable oil: metabolic actions. Lipids. 2008;43(11):989-97.
335. Benzecry EH, Pinheiro AB, Lacerda EM. Tabela para avaliagao de consumo alimentar em medidas caseiras. 4a ed. Sao Paulo: Atheneu; 2000.
336. Elizabeth Stewart Hand and Associates (ESHA Research). The food processor SQL, version 10.5.0. Salem, (Oregon);2008.